title: Possibilities and limitations of signal summing for an immunosuppressant LC-MS/MS method.
abstract: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the method of choice for quantifying small molecules in research and clinical setting. Although there is a large toolkit to increase quantification levels for LC-MS/MS, these techniques are sometimes insufficient to attain the needed limits of quantification (LOQs) or the method becomes too impractical for routine use. We examined the possibilities and limitations of signal summing, an under-utilized, easy-to-apply practice to increase LOQs for an immunosuppressant LC-MS/MS method. The limits of signal summing for everolimus were tested by running samples of everolimus at three concentrations in triplicate programming, increasing amounts of identical transitions in a constant cycle time up to the maximum number the software permitted to sum. The increase in peak area and the signal-to-noise ratio were determined. The effect on imprecision of peak areas and response ratios was evaluated by injection of a low concentration of everolimus tenfold using respectively one and five identical transitions, retaining an identical ion counting time. We compared the imprecision, LOQ, and recovery for our routine everolimus method (using one transition for everolimus and one for d3-everolimus) and an adapted method summing three identical transitions for everolimus (and one for d3-everolimus). The increase in signal was close to the theoretically expected one with a larger experimental spread for everolimus once more than five transitions were used. There was no clear beneficial effect of summing on imprecision. The adapted everolimus method showed a lower LOQ, but comparable imprecision and recovery as the routine method. Quantification levels can be improved by signal summing. No clear effect on imprecision was observed.
authors.affiliation: Clinical Department of Laboratory Medicine, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium, steven.pauwels@uzleuven.be.
authors.forename: Steven
authors.initials: S
authors.lastname: Pauwels
authors.forename: Ivo
authors.initials: I
authors.lastname: Jans
authors.forename: Nele
authors.initials: N
authors.lastname: Peersman
authors.forename: Jaak
authors.initials: J
authors.lastname: Billen
authors.forename: Dirk
authors.initials: D
authors.lastname: Vanderschueren
authors.forename: Koen
authors.initials: K
authors.lastname: Desmet
authors.forename: Pieter
authors.initials: P
authors.lastname: Vermeersch
mesh_terms: D002853:Chromatography, Liquid / Q000379:methods*; D016903:Drug Monitoring / Q000379:methods; D000068338:Everolimus / Q000032:analysis / Q000097:blood*; D006801:Humans; D007166:Immunosuppressive Agents / Q000032:analysis / Q000097:blood*; D057230:Limit of Detection; D015203:Reproducibility of Results; D059629:Signal-To-Noise Ratio; D012984:Software; D053719:Tandem Mass Spectrometry / Q000379:methods*
chemical_list: D007166:Immunosuppressive Agents; D000068338:Everolimus